B Löwenberg Selected Research

B Löwenberg Research Topics

Disease

11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 01/2000
4	Leukemia 07/2014 - 03/2000
3	Acute Promyelocytic Leukemia 04/2016 - 01/2001
3	Multiple Sclerosis 12/2006 - 01/2006
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2002 - 08/2000
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2016 - 03/2001
2	Neoplasms (Cancer) 02/2015 - 03/2001
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2007 - 01/2002
2	Autoimmune Diseases (Autoimmune Disease) 12/2006 - 05/2005
2	Thrombocytopenia (Thrombopenia) 10/2002 - 06/2000
2	Infections 09/2001 - 07/2001
1	Hemorrhage 04/2016
1	Disseminated Intravascular Coagulation 04/2016
1	Thrombosis (Thrombus) 04/2016
1	Wilms Tumor (Wilm's Tumor) 03/2010
1	Hematologic Neoplasms (Hematological Malignancy) 04/2006
1	Lymphopenia (Lymphocytopenia) 04/2006
1	Disease Progression 01/2006
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2006
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2006
1	Thrombotic Thrombocytopenic Purpura 09/2005
1	Blast Crisis (Blast Phase) 01/2002
1	Hyperbilirubinemia 07/2001
1	Mucositis 07/2001
1	Philadelphia Chromosome 03/2001
1	Neoplasm Metastasis (Metastasis) 03/2001
1	Hodgkin Disease (Hodgkin's Disease) 03/2001
1	Lymphoma (Lymphomas) 02/2001
1	Genetic Translocation (Chromosomal Translocation) 07/2000
1	Leukopenia 06/2000
1	Neutropenia 04/2000
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2000

Drug/Important Bio-Agent (IBA)

3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2007 - 01/2000
3	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2001 - 02/2001
2	Proteins (Proteins, Gene)FDA Link 07/2014 - 01/2001
2	CytokinesIBA 04/2006 - 07/2001
2	AntibodiesIBA 01/2006 - 03/2000
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2005 - 01/2001
2	Biological ProductsIBA 07/2001 - 04/2000
2	Retinoic Acid Receptor alphaIBA 01/2001 - 07/2000
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2000 - 01/2000
2	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2000 - 01/2000
1	Dacarbazine (DIC)FDA LinkGeneric 04/2016
1	fibrin fragment D (D-dimer)IBA 04/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Inositol (Myoinositol)IBA 07/2015
1	proto-oncogene protein Spi-1IBA 07/2014
1	Nonsense Codon (Nonsense Mutation)IBA 03/2010
1	Messenger RNA (mRNA)IBA 03/2010
1	Interferon-alpha (Interferon Alfa)IBA 02/2007
1	HLA-DR Antigens (HLA-DR)IBA 04/2006
1	thiamine triphosphorate (TTP)IBA 09/2005
1	Phosphotransferases (Kinase)IBA 01/2002
1	Imatinib Mesylate (Gleevec)FDA Link 01/2002
1	Tyrosine Kinase InhibitorsIBA 01/2002
1	Transaminases (Aminotransferases)IBA 07/2001
1	Gemtuzumab (Mylotarg)FDA Link 07/2001
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2001
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 01/2001
1	RetinoidsIBA 01/2001
1	Prednisone (Sone)FDA LinkGeneric 08/2000
1	Etoposide (VP 16)FDA LinkGeneric 08/2000
1	Mitoxantrone (Novantrone)FDA LinkGeneric 08/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2000
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2000
1	Pharmaceutical PreparationsIBA 06/2000
1	Carrier Proteins (Binding Protein)IBA 06/2000
1	BilirubinIBA 04/2000
1	valspodar (PSC 833)IBA 01/2000

Therapy/Procedure

8	Therapeutics 07/2015 - 04/2000
5	Stem Cell Transplantation 12/2006 - 01/2002
5	Transplantation 12/2006 - 03/2001
4	Drug Therapy (Chemotherapy) 04/2016 - 07/2001
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2006
1	Plasma Exchange 09/2005
1	Splenectomy 09/2005
1	Hematopoietic Stem Cell Transplantation 05/2005
1	Induction Chemotherapy 01/2000